Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cannon

Showing results (581-590 of 10,773) with videos related to

Pageof 1,078
Sort By:
Clinical Cardiology|October 4, 2003
Oral platelet glycoprotein IIb/IIIa receptor inhibitors--part IIChristopher P Cannon
Pharmacoeconomics|May 7, 2005
Cost-effectiveness of clopidogrelChristopher P Cannon
Health & Social Work|April 26, 2005
The lion at the gate: an HIV-affected caregiver resists stigmaCynthia Cannon Poindexter
Thrombosis Research|June 7, 2005
WITHDRAWN: NIH conference on dietary supplements, coagulation, and antithrombotic therapies Session V. Panel experts: Opinions and research priorities; supplements affecting antithrombotic therapies: A cardiologist's perspective. Dietary supplements and the management of atrial fibrillationRichard O Cannon
Circulation|June 1, 1975
Radioisotopic studies of the regional myocardial circulationP J Cannon
Current Opinion in Psychiatry|April 28, 2006
The inheritance of intermediate phenotypes for schizophreniaTyrone D Cannon
Northwest Dentistry|April 1, 2006
When the walls come tumbling down a pathway to recovery: episode twoPeter N Cannon
Northwest Dentistry|February 4, 2006
When the walls come tumbling down: a pathway to addictionPeter N Cannon
American Heart Journal|February 28, 2002
To cath or not to cath? That used to be the questionChristopher P Cannon
Clinical Cornerstone|May 3, 2008
Cardiovascular disease and modifiable cardiometabolic risk factorsChristopher P Cannon
Pageof 1,078

Showing results (581-590 of 10,773) with videos related to

Sort By:
Pageof 1,078
Clinical Cardiology|October 4, 2003
Oral platelet glycoprotein IIb/IIIa receptor inhibitors--part IIChristopher P Cannon
Pharmacoeconomics|May 7, 2005
Cost-effectiveness of clopidogrelChristopher P Cannon
Health & Social Work|April 26, 2005
The lion at the gate: an HIV-affected caregiver resists stigmaCynthia Cannon Poindexter
Thrombosis Research|June 7, 2005
WITHDRAWN: NIH conference on dietary supplements, coagulation, and antithrombotic therapies Session V. Panel experts: Opinions and research priorities; supplements affecting antithrombotic therapies: A cardiologist's perspective. Dietary supplements and the management of atrial fibrillationRichard O Cannon
Circulation|June 1, 1975
Radioisotopic studies of the regional myocardial circulationP J Cannon
Current Opinion in Psychiatry|April 28, 2006
The inheritance of intermediate phenotypes for schizophreniaTyrone D Cannon
Northwest Dentistry|April 1, 2006
When the walls come tumbling down a pathway to recovery: episode twoPeter N Cannon
Northwest Dentistry|February 4, 2006
When the walls come tumbling down: a pathway to addictionPeter N Cannon
American Heart Journal|February 28, 2002
To cath or not to cath? That used to be the questionChristopher P Cannon
Clinical Cornerstone|May 3, 2008
Cardiovascular disease and modifiable cardiometabolic risk factorsChristopher P Cannon
Pageof 1,078